PubRank

REmoval of Free Light Chains. A COmpaRison of Three Different dialyzERs (RECORDER)

Clinical Trial ID NCT02950389

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02950389

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003 3.54
2 Immunoglobulin light chains in uremia. Kidney Int Suppl 2003 0.99
3 Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. Nephrol Dial Transplant 2002 0.98
4 Clinical significance of protein adsorbable membranes--long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007 0.93
5 Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis. Nephrol Dial Transplant 2011 0.86
6 Serum free light chains and the risk of ESRD and death in CKD. Clin J Am Soc Nephrol 2011 0.86
7 No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987 0.86
8 Protein adsorption by artificial membrane materials under filtration conditions. Artif Organs 1995 0.84
9 Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: a multicenter longitudinal study. Hemodial Int 2014 0.84
10 Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007 0.83
11 Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs 2013 0.81
12 Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone. Int J Artif Organs 2003 0.81
13 A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR). J Nephrol 2014 0.81
14 Novel approaches for reducing free light chains in patients with myeloma kidney. Nat Rev Nephrol 2012 0.80
15 Reduction of free immunoglobulin light chains using adsorption properties of hemodiafiltration with endogenous reinfusion. Blood Purif 2010 0.80
16 Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins (Basel) 2013 0.80
17 Efficacy of haemodiafiltration treatment with PEPA dialysis membranes in plasma free light chain removal in a patient with primary amyloidosis. Nephrol Dial Transplant 2002 0.78
18 Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients. J Nephrol 2015 0.78
19 Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties. Blood Purif 2013 0.78
20 Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy. PLoS One 2015 0.78
21 The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma. Blood Purif 2013 0.78
22 Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal. Blood Purif 2014 0.77
23 Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers. BMC Nephrol 2016 0.75
Next 100